INFANRIX IPV HIB

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Hong Kong SAR China, Lithuania, New Zealand, Poland, Singapore, Tunisia, Turkey, UK.

Active ingredients

The drug INFANRIX IPV HIB contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE
 
Read more about Diphtheria toxoid
2
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
 
Read more about Tetanus toxoid
3
 
Read more about Pertussis toxoid
4
UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
 
Read more about Pertussis filamentous hemagglutinin
5
UNII 2QNL82089R - BORDETELLA PERTUSSIS
 
Read more about Pertactin
6
UNII 0LVY784C09 - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
 
Read more about Poliomyelitis, serotype 1
7
UNII 23JE9KDF4R - POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
 
Read more about Poliomyelitis, serotype 2
8
UNII 459ROM8M9M - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
 
Read more about Poliomyelitis, serotype 3
9
UNII FLV5I5W26R - HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
 

Haemophilus influenza type B (Hib) is a bacteria responsible for severe pneumonia, meningitis and other invasive diseases almost exclusively in young children. Vaccines are the only public health tool capable of preventing the majority of serious Hib disease.

 
Read more about Haemophilus influenzae B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07CA06 Diphtheria-Haemophilus influenzae B-pertussis-poliomyelitis-tetanus J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined
Discover more medicines within J07CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1043851
GB Medicines & Healthcare Products Regulatory Agency 107766
HK Department of Health Drug Office 47367
HR Agencija za lijekove i medicinske proizvode HR-H-255493749
LT Valstybinė vaistų kontrolės tarnyba 1006003
NZ Medicines and Medical Devices Safety Authority 8484
PL Rejestru Produktów Leczniczych 100194053
SG Health Sciences Authority 10988P
TN Direction de la Pharmacie et du Médicament 7063101
TR İlaç ve Tıbbi Cihaz Kurumu 8699522967421

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.